This inventor holds 1 USPTO granted patent. Top assignees: Health Protection Agency, Syntaxin Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 38 
1 out of 36 
Years Active: 2010
Title: The Innovations of Charles Clifford Shone
Introduction
Charles Clifford Shone is a notable inventor based in Salisbury, GB. He is recognized for his contributions to the field of biotechnology, particularly in the development of antigenic compositions that have significant implications for immunization and treatment against clostridial neurotoxin poisoning. With a total of 1 patent, his work exemplifies the intersection of science and innovation.
Latest Patents
Shone's patent focuses on recombinant toxin fragments. The invention provides antigenic compositions that comprise a single chain polypeptide with distinct domains. The first domain is derived from a clostridial neurotoxin light chain, which is capable of cleaving essential proteins for exocytosis. The second domain, a clostridial neurotoxin heavy chain portion, enhances the polypeptide's ability to translocate into cells or increases its solubility. This innovative approach also includes antibodies that bind to the polypeptides and DNA vaccines that encode these polypeptides, offering new methods for immunization and treatment.
Career Highlights
Throughout his career, Shone has worked with prominent organizations such as the Health Protection Agency and Syntaxin Limited. His experience in these institutions has allowed him to contribute significantly to advancements in medical biotechnology. His work has not only advanced scientific understanding but also provided practical solutions for health-related challenges.
Collaborations
Shone has collaborated with notable professionals in his field, including Conrad Padraig Quinn and Keith Foster. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Charles Clifford Shone's contributions to biotechnology through his innovative patent on recombinant toxin fragments highlight the importance of scientific research in addressing health issues. His work continues to inspire advancements in immunization and treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile